Profile of Serum IL-1β and IL-10 Shortly after Ovariectomy and Estradiol Replacement in Rats

Abstract

Ovariectomy leads to progressive and significant increases in body weight gain and osteoporosis and is related to changes in serum and tissue cytokine profiles, such as observed in other models of overweight. We aimed to evaluate serum interleukin-1β and interleukin-10 shortly after ovariectomy, before the establishment of overweight in rats. Female Wistar rats were submitted to ovariectomy, ovariectomy and estradiol replacement, or sham operation and compared with intact controls. Rats were killed 3, 6, 9, or 13 d after ovariectomy. Body mass and retroperitoneal fats were significant higher only 13 d after ovariectomy, and estradiol replacement to ovariectomized rats impaired both body mass and retroperitoneal fat gain. Shortly after ovariectomy (at 3 d) serum interleukin-1β levels significantly increased in ovariectomized rats, treated or not with estradiol, while serum interleukin-10 levels increased only 9 d after ovariectomy. Our results suggest the existence of an important interplay between the immune system and ovarian function. This interplay occurs regardless of significant changes in adipose tissue compartment, as ovarian excision leads to short-term changes in the pattern of interleukin-1β and interleukin-10 cytokine production that precede body weight gain and are not reverted by estradiol replacement.

castration - menopause - estrogen - adipose tissue - overweight - cytokine - immune system

References

• 1 Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update.  Clin Endocrinol. 2006;  64 355-365
• 2 Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue.  Br J Nutr. 2004;  92 347-355
• 3 Aygun AD, Gungor S, Ustundag B, Gurgoze MK, Sen Y. Proinflammatory cytokines and leptin are increased in serum of prepubertal obese children.  Mediators Inflamm. 2005;  14 180-183
• 4 Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells.  Vitam Horm. 2006;  74 443-477
• 5 Gèrard N, Caillaud M, Martoriati A, Goudet G, Lalmanach A-C. The interleukin-1 system and female reproduction.  J Endocrinol. 2004;  180 203-212
• 6 Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period.  Endocrinology. 1995;  136 3054-3061
• 7 Bornstein SR, Rutkowski H, Vrezas I. Cytokines and steroidogenesis.  Mol Cell Endocrinol. 2004;  215 135-141
• 8 Oshima S, Onodera S, Amizuka N, Li M, Irie K, Watanabe S, Koyama Y, Nishihira J, Yasuda K, Minami A. Macrophage migration inhibitory factor-deficient mice are resistant to ovariectomy-induced bone loss.  FEBS Lett. 2006;  580 1251-1256
• 9 Vural P, Akgul C, Canbaz M. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women.  Pharmacol Res. 2006;  54 298-302
• 10 Berg G, Ekerfelt C, Hammar M, Lindgren R, Matthiesen L, Ernerudh J. Cytokine changes in postmenopausal women treated with estrogens: a placebo-controlled study.  Am J Reprod Immunol. 2002;  48 63-69
• 11 Cioffi M, Esposito K, Vietri MT, Gazzerro P, D’Auria A, Ardovino I, Puca GA, Molinari AM. Cytokine pattern in postmenopause.  Maturitas. 2002;  41 187-192
• 12 O’Brien SM, Fitzgerald P, Scully P, Landers A, Scott LV, Dinan TG. Impact of gender and menstrual cycle phase on plasma cytokine concentrations.  Neuroimmunomodulation. 2007;  14 84-90
• 13 Hildebrand F, Hubbard WJ, Choudhry MA, Thobe BM, Pape HC, Chaudry IH. Are the protective effects of 17beta-estradiol on splenic macrophages and splenocytes after trauma-hemorrhage mediated via estrogen-receptor (ER)-alpha or ER-beta?.  J Leukoc Biol. 2006;  79 1173-1180
• 14 Islander U, Erlandsson MC, Hasséus B, Jonsson CA, Ohlsson C, Gustafsson JA, Dahlgren U, Carlsten H. Influence of oestrogen receptor alpha and beta on the immune system in aged female mice.  Immunology. 2003;  110 149-157
• 15 Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, MacCracken R, Avioli LV. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells.  Proc Natl Acad Sci USA. 1991;  88 5134-5138
• 16 Lima LP, Barros IA, Lisbôa PC, Araújo RL, Silva AC, Rosenthal D, Ferreira AC, Carvalho DP. Estrogen effects on thyroid iodide uptake and thyroperoxidase activity in normal and ovariectomized rats.  Steroids. 2006;  71 653-659
• 17 Alonso A, Fernández R, Moreno M, Ordóñez P, Díaz F, González C. Leptin and its receptor are controlled by 17beta-estradiol in peripheral tissues of ovariectomized rats.  Exp Biol Med. 2007;  232 542-549
• 18 Gutkowska J, Paquette A, Wang D, Lavoie JM, Jankowski M. Effect of exercise training on cardiac oxytocin and natriuretic peptide systems in ovariectomized rats.  Am J Physiol Regul Integr Comp Physiol. 2007;  293 R267-R275
• 19 Ainslie DA, Morris MJ, Wittert G, Turnbull H, Proietto J, Thorburn AW. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y.  Int J Obes Relat Metab Disord. 2001;  25 1680-1688
• 20 Liang YQ, Akishita M, Kim S, Ako J, Hashimoto M, Iijima K, Ohike Y, Watanabe T, Sudoh N, Toba K, Yoshizumi M, Ouchi Y. Estrogen receptor beta is involved in the anorectic action of estrogen.  Int J Obes Relat Metab Disord. 2002;  26 1103-1109
• 21 Hrupka BJ, Smith GP, Geary N. Hypothalamic implants of dilute estradiol fail to reduce feeding in ovariectomized rats.  Physiol Behav. 2002;  77 233-241
• 22 Shimizu H. Withdrawal of [corrected] estrogen increases hypothalamic neuropeptide Y (NPY) mRNA expression in ovariectomized obese rat.  Neurosci Lett. 1996;  204 81-84
• 23 Marassi MP, Fortunato RS, da Silva AC, Pereira VS, Carvalho DP, Rosenthal D, da Costa VM. Sexual dimorphism in thyroid function and type 1 iodothyronine deiodinase activity in pre-pubertal and adult rats.  J Endocrinol. 2007;  192 121-130
• 24 Mauriège P, Martel C, Langin D, Lacaille M, Després JP, Bélanger A, Labrie F, Deshaies Y. Chronic effects of dehydroepiandrosterone on rat adipose tissue metabolism.  Metabolism. 2003;  52 264-272
• 25 Lafontan M. Fat cells: afferent and efferent messages define new approaches to treat obesity.  Annu Rev Pharmacol Toxicol. 2005;  45 119-146
• 26 MohanKumar SM, Smith CL, MohanKumar PS. Central adaptation to chronic administration of interleukin-1beta (IL-1beta) in rats.  Brain Res Bull. 2003;  62 71-76
• 27 García MC, Wernstedt I, Berndtsson A, Enge M, Bell M, Hultgren O, Horn M, Ahrén B, Enerback S, Ohlsson C, Wallenius V, Jansson JO. Mature-onset obesity in interleukin-1 receptor I knockout mice.  Diabetes. 2006;  55 1205-1213
• 28 Esposito K, Pontillo A, Giugliano F, Giugliano G, Marfella R, Nicoletti G, Giugliano D. Association of low interleukin-10 levels with the metabolic syndrome in obese women.  J Clin Endocrinol Metab. 2003;  88 1055-1058
• 29 Biffoni M, Marcucci I, Ythier A, Eshkol A. Effects of urinary gonadotrophin preparations on human in vitro immune function.  Hum Reprod. 1998;  13 2430-2434
• 30 Rachoñ D, Vortherms T, Seidlová-Wuttke D, Wuttke W. Effects of dietary equol on the pituitary of the ovariectomized rats.  Horm Metab Res. 2007;  39 256-261

Correspondence